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Campylobacter jejuni is the leading cause of bacterial food-borne diarrhoeal disease throughout the world, and yet
is still a poorly understood pathogen. Whole genome microarray comparisons of 11 C. jejuni strains of diverse
origin identified genes in up to 30 NCTC 11168 loci ranging from 0.7 to 18.7 kb that are either absent or highly
divergent in these isolates. Many of these regions are associated with the biosynthesis of surface structures
including flagella, lipo-oligosaccharide, and the newly identified capsule. Other strain-variable genes of known
function include those responsible for iron acquisition, DNA restriction/modification, and sialylation. In fact, at
least 21% of genes in the sequenced strain appear dispensable as they are absent or highly divergent in one or
more of the isolates tested, thus defining 1300 C. jejuni core genes. Such core genes contribute mainly to
metabolic, biosynthetic, cellular, and regulatory processes, but many virulence determinants are also conserved.
Comparison of the capsule biosynthesis locus revealed conservation of all the genes in this region in strains with
the same Penner serotype as strain NCTC 11168. By contrast, between 5 and 17 NCTC 11168 genes in this region
are either absent or highly divergent in strains of a different serotype from the sequenced strain, providing
further evidence that the capsule accounts for Penner serotype specificity. These studies reveal extensive genetic
diversity among C. jejuni strains and pave the way toward identifying correlates of pathogenicity and developing
improved epidemiological tools for this problematic pathogen.
Campylobacter jejuni is the principal cause of human bacterial
gastroenteritis worldwide (Blaser 1997). Disease outcomes
from C. jejuni infection vary from mild, noninflammatory,
self-limiting diarrhoea to severe, inflammatory, bloody diar-
rhoea lasting for several weeks (Wassenaar and Blaser 1999).
In addition, C. jejuni is also associated with the development
of the peripheral neuropathies Miller Fisher and Guillain-
Barré (GBS) syndromes (Nachamkin et al. 1998), which fur-
ther adds to the economic burden of C. jejuni infection (Buzby
et al. 1997). Given the range of disease outcomes and the
importance of C. jejuni as a major economic and social prob-
lem, it is surprising that the ecology, epidemiology, and, in
particular, the pathogenesis of the organism are so poorly
understood. This lack of understanding was the driving force
for instigating the recently completed C. jejuni genome
project (Parkhill et al. 2000).
The sequencing of the C. jejuni NCTC 11168 genome
revealed few mechanisms by which the organism can gener-
ate genetic diversity. C. jejuni is almost unique among se-
quenced bacterial pathogens in that the NCTC 11168 genome
sequence contains no transposons, phage remnants, or inser-
tion sequence elements and very few repeat sequences. How-
ever, several lines of evidence have indicated relative intra-
specific genotypic and phenotypic diversity compared to
other enteropathogens. For example, two serotyping schemes
detect a wide variety of serotypes: the Penner heat-stable an-
tigen typing scheme detects more than 60 serotypes (Penner
and Hennessy 1980), whereas the Lior heat-labile antigen typ-
ing scheme recognizes >100 serotypes (Lior et al. 1982). Ge-
notypic diversity has been shown by ribotyping, pulsed field
gel electrophoresis, and several PCR-based techniques (Fayos
et al. 1992; Lam et al. 1995; Hanninen et al. 1999; Kokotovic
and On 1999). Unfortunately, these methods are unable to
further characterize the genetic basis for this observed vari-
ability. Diversity between C. jejuni strains has also been ob-
served at the phenotypic level, particularly for characteristics
implicated in pathogenicity, such as adherence to and inva-
sion of epithelial cell lines (Konkel and Joens 1989; Everest et
al. 1992; Wooldridge and Ketley 1997), toxin production
(Wassenaar 1997), serum resistance (Blaser et al. 1986), exo-
polysaccharide production (Karlyshev et al. 2000a), sialyla-
tion of LOS (Linton et al. 2000b), and the ability to colonize
chicks (Korolik et al. 1998; Barrow and Page 2000).
The Penner serotyping system has been used worldwide
for grouping C. jejuni strains for more than 20 years (Penner
and Hennessy 1980). Important epidemiological correlations
have been made on the basis of this typing system, including
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the overrepresentation of serotype O:19 strains isolated in
GBS patients (Yuki and Miyatake 1998) and a cluster of GBS
cases linked with serotype O:41 (Prendergast et al. 1998).
Problems associated with the Penner serotyping system in-
clude difficulty in standardizing preparation of antisera, the
expense of specific sera, and a significant proportion of un-
typable strains. Surprisingly, despite the widespread use of the
Penner serotyping system, the nature of the serotypic deter-
minant was until recently unclear. Data now indicate that the
heat-stable Penner serotyping antigen is the newly recognized
capsular polysaccharide (Karlyshev et al. 2000a).
DNA microarrays have been used to compare interstrain,
intraspecific variations in bacteria at the genomic level, re-
ferred to as genomotyping. For example, to investigate the
differences betweenMycobacterium tuberculosis,Mycobacterium
bovis, and the various BCG vaccine daughter strains, their
genomic compositions were studied by comparative hybrid-
ization experiments using a M. tuberculosis H37Rv DNA mi-
croarray (Behr et al. 1999). These experiments highlighted
many regions of the virulent M. tuberculosis H37Rv reference
strain that were lacking inM. bovis and the BCG strains. More
recently, use of a whole genome microarray from two se-
quenced strains revealed diversity among clinical isolates of
the gastric pathogen Helicobacter pylori, which is closely re-
lated to C. jejuni. This study identified a class of candidate
virulence genes by their coinheritance with the well-
characterized H. pylori cag pathogenicity island (Salama et al.
2000).
To date there appears to be very little sequence diversity
between housekeeping genes from different C. jejuni strains,
particularly between human isolates (Dingle et al. 2001;
Suerbaum et al. 2001). Genes that encode surface-exposed
antigenic proteins are known to vary in sequence, presumably
to evade the immune system. The flagellin structural genes
flaA and flaB both have hypervariable regions that probably
correspond to surface-exposed parts of the proteins. However,
genes that encode other nonimmunogenic virulence factors
appear to be closely conserved. For example, OmpH1 and
Peb1A are both surface exposed on the bacteria, but there
does not appear to be the selection for diversity in the ompH1
and peb1A genes that is seen with the flagellin structural
genes (for review, see Meinersmann 2000). Furthermore, the
NCTC 11168 genome contains very few repeat sequences
(<1% of the genome) (Parkhill et al. 2000). Therefore, C. jejuni
would appear to be an ideal organism to study by genomo-
typing.
One of the drawbacks of microarray technology is the
initial high cost involved in the synthesis of gene-specific
primers to amplify each gene in a genome. The 10-fold se-
quencing of the C. jejuni NCTC 11168 genome provided the
useful by-product of an ordered library of sequence-defined
pUC18 clones covering the entire genome (Parkhill et al.
2000). Optimum clones for all putative coding sequences
(CDS) were selected, and PCR products were amplified from
these clones using a single pair of vector primers. These PCR
products were spotted onto glass slides to produce a low-cost
C. jejuni whole genome microarray. Although only 34.5% of
the PCR products were gene-specific, this type of microarray is
suitable for performing genomotyping, where the data gener-
ated are qualitative rather than quantitative. The aim of our
study was to use this microarray to investigate the extent of
genetic diversity among C. jejuni isolates, and more specifi-
cally, the relationship between capsule locus variability and
Penner serotype.
RESULTS
Construction of the C. jejuni NCTC 11168 Whole
Genome DNA Microarray
A whole genome DNAmicroarray was constructed containing
an element representing each of the 1731 CDSs originally
identified from the genome sequence (J. Parkhill, unpubl.).
The number of annotated CDSs in the C. jejuni NCTC 11168
genome was subsequently reduced to 1654 (Parkhill et al.
2000). The resulting 77 “nongenes” are therefore each flagged
in the gene lists used in the analysis software as a “not anno-
tated gene”. The tiling program, designed to identify the op-
timum clone for each CDS from the ordered pUC18 plasmid
library, identified clones containing a single gene fragment
for 597 (34.5%) of the CDSs. For 613 (35.4%) of the CDSs, a
further set of clones was identified with an adjacent gene
fragment either upstream or downstream of the selected gene.
The remaining 521 (30.1%) CDSs are represented by clones
containing more than one gene fragment adjacent to the se-
lected gene. The size range of the vector primer-amplified PCR
products was 0.5 kb to 2.0 kb. Controls comprised the 5S, 16S,
and 23S rRNA genes (with four serial fourfold dilutions of the
23S rRNA gene), the multiple cloning site of the pUC18 vec-
tor, and the human -actin gene. The controls were printed
along the top row of each of the 16 subgrids.
General Features of Interstrain Whole
Genome Hybridizations
The data generated are available on-line at http://www.
sghms.ac.uk/depts/medmicro/bugs/GR-1858. One of the limi-
tations of using a microarray generated using plasmid clones
rather than gene-specific primers is the potential difficulty in
interpreting the data owing to the presence of overlapping
genes on the microarray. If a gene is absent, but is represented
by a clone containing adjacent genes that are pres-
ent, then the red/green hybridization signal intensity ratio
may be raised above 0.5 and the gene subsequently scored as
present. However, genes scored as absent or highly divergent
should be accurate within the limits of array technology.
The results presented identify regions of the NCTC
11168 genome ranging from <0.5 kb to nearly 20 kb to which
genomic DNA from one or more of the 11 test strains listed in
Table 1 failed to hybridize. Table 1 also shows the percentage
of NCTC 11168 genes to which genomic DNA from each
strain failed to hybridize. Genes can therefore be identified
that are absent or highly divergent in these strains. Such ge-
nome content data indicates that of the 11 strains analyzed,
strains 81116 and P3 are most distantly related to NCTC
11168, whereas the recent clinical isolate PHLS03 is most
closely related to the sequenced strain.
Figure 1 indicates the position of absent or highly diver-
gent genes over the whole genome of each of the 11 isolates,
assuming gene order conservation among strains. The com-
plete lists of genes either absent or highly divergent in each of
the 11 strains tested are also available on-line at http://
www.sghms.ac.uk/depts/medmicro/bugs/GR-1858. Of the
1654 annotated genes, 1300 were common to all strains (core
genes), with 354 genes missing from at least one strain (vari-
able genes). As expected, conserved regions included genes for
metabolic, biosynthetic, cellular, and regulatory processes,
but also for several putative virulence determinants, includ-
ing genes encoding the cytolethal distending toxin (Pickett et
al. 1996), flagellar structural proteins (Wassenaar et al. 1991),
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phospholipase A (Grant et al. 1997), the PEB antigenic surface
proteins (Pei et al. 1991), and proteins potentially involved in
host pathogen interactions such as CiaB (Konkel et al. 1999),
CadF (Konkel et al. 1997), and CheY (Yao et al. 1997). Variable
genes of known function that are not involved in surface
structure include the iron acquisition siderophore receptor
(Cj0178), which is absent or highly divergent in 81116 and
81-176, and the enterochelin uptake operon ceuBCDE, which
is absent or highly divergent in strain PHLS02. The predicted
DNA restriction and DNA modification systems in NCTC
TABLE 1. Campylobacter jejuni Strains Used in This Study
Strain Relevant characteristics and history Penner serotype
% genes
non-hybridized Source/Reference
11168 Sequenced strain, human isolate (Worcester 1977) O:2 0 NCTC 11168a
81116 Human isolate, source: water (Chelmsford 1981) O:6 6.95 NCTC 81116b
81-176 Human isolate, source: raw milk (Minnesota 1981) O:23/36 3.93 G. Perez-Perezc
X Human isolate, gastroenteritis, source: poultry (London 1997) UTd 1.27 A. Karlysheve
G1 Human isolate, GBSf O:1 1.21 N. Gregsong
P1 Penner serotype reference strain O:1 3.69 NCTC 12500h
P2 Penner serotype reference strain O:2 3.69 NCTC 12501h
P3 Penner serotype reference strain O:3 6.95 NCTC 12502h
P4 Penner serotype reference strain O:4 3.87 NCTC 12561h
PHLS01 Human isolate, phage type 35 O:2 3.51 PHLS (C0118480)h
PHLS02 Human isolate, phage type 1 O:2 3.39 PHLS (C0178110)h
PHLS03 Human isolate, phage type 44 O:2 0.54 PHLS (C0125990)h
aNature Collection of Type Cultures, Colindale, London
bVeterinary Laboratories Agency, Weybridge, UK
cVanderbilt University, Nashville, Tennessee
dUntypeable
eLSHTM, London UK
fStrain from patient who later developed Guillain-Barre´ syndrome
gGuy’s Medical School, London
hPublic Health Laboratory Service, Colindale, London
Figure 1 Comparison of the genomes of 11 different Campylobacter jejuni strains with the NCTC 11168 genome. Genes identified as absent by
microarray hybridization analysis are indicated as a vertical line depicting the position of the gene in a linear representation of the 1.64-Mb NCTC
11168 genome from Cj0001to Cj1654. Lines above the horizontal line indicate genes on the forward strand, and lines below indicate genes on
the reverse strand. (LOS) Lipo-oligosaccharide biosynthesis locus, (FM) flagellar modification locus, and (CAP) capsule biosynthesis locus.
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11168 appear to be particularly variable, with many of these
systems absent or highly divergent in strains 81116, 81-176,
X, P1, P2, P3, and P4 (Table 2).
Cluster analysis to compare the genome content of the
11 strains studied was performed (Fig. 2). Such analysis indi-
cates that even though strains P2, PHLS01, PHLS02, and
PHLS03 share the same serotype, the genome content of these
strains is otherwise dissimilar.
Variation in Surface Structures
Many of the C. jejuni NCTC 11168 genes absent or highly
divergent in one or more strains are associated with the syn-
thesis and/or modification of surface structures. Data for the
three large gene clusters representing capsular polysaccharide
biosynthesis (Cj1413–Cj1448), LOS biosynthesis (Cj1131–
Cj1152), and the region involved in biosynthesis and post-
translational modification of the flagellin subunits FlaA and
FlaB (Cj1305–Cj1345) are represented in Figure 1. Strains
81116 and 81-176 lack much of the NCTC11168 flagellin
modification locus, which is conserved in the other nine
strains tested. This has been confirmed for strain 81116 by
PCR analysis (A.V. Karlyshev, unpubl.). The capsule and LOS
hybridization patterns for the 11 strains are detailed in Tables
3 and 4, respectively.
The C. jejuni capsular polysaccharide was recently iden-
tified as the serodeterminant of the Penner serotyping system
(Karlyshev et al. 2000a). The organization of the C. jejuni cap-
sule locus bears similarity to the Escherichia coli paradigm, in
which conserved genes associated with transport of the poly-
saccharide (kps genes; see Table 3) flank a central region that
in E. coli is the variable biosynthetic region involved in the
generation of diverse polysaccharide structures (Roberts
1996). It was predicted that if this central region does indeed
contain the genes involved in C. jejuni capsular polysaccha-
ride biosynthesis, then this region would vary between strains
of different Penner serotypes (Karlyshev et al. 2000a). In-
deed, the seven non-O:2 serotype strains revealed exten-
sive diversity, with up to 17 NCTC 11168 genes absent or
highly divergent from this central region (Table 3). A striking
feature of the genome comparisons is the complete con-
servation of the 42.6-kb capsule biosynthesis locus in
four strains with the same Penner serotype (O:2) as the se-
quenced strain (Table 3). This clearly indicates that this
central biosynthetic region is responsible for the variation in
capsular polysaccharide detected by the Penner serotyping
system. As expected, the kps genes flanking the central cap-
Table 2. Divergence in Restriction/Modification Systems in Campylobacter jejuni Strains
Gene Functiona
Clone content
(%)
Phase
variableb 81116 81-176 X G1 P1 P2 P3 P4
PHLS
01
PHLS
02
PHLS
03
Cj0031 type IIS restriction/
modification enzyme,
N-terminal half
Cj0031 (31)  + + + + + + + + + + +
Cj0032 type IIS restriction/
modification enzyme,
C-terminal half
Cj0031 (8)
Cj0032 (95)
  +  +  + (+)  + + (+)
Cj0208 DNA modification
methylase
Cj0207 (1)
Cj0208 (66)
+ + + + + + + + + + +
Cj0690 possible restriction/
modification enzyme
Cj0690 (34)  + + + + (+) + + + + +
Cj0722 DNA methylase Cj0721 (16)
Cj0722 (100)
Cj0723 (32)
+ + + + + (+) + + (+) + +
Cj1051 restriction/modification
enzyme
Cj1051 (25) +  + + +   + + + (+)
Cj1549 type I restriction enzyme R
protein
Cj1549 (27)  + + + + + +  + + +
Cj1551 type I restriction enzyme S
protein
Cj1551 (56)  + + + + + +  + + +
Cj1553 type I restriction enzyme M
protein
Cj1553 (39) + + + + + + +  + + +
A + or  indicates that the red/green hybridization signal intensity ratio is >0.5 or <0.5. respectively.
(+) Indicates the possibility that the gene may be absent or highly divergent even though the red/green hybridization signal intensity ratio is
> 0.5 (see Methods).
aPutative gene function based on annotation (Parkhill et al. 2000).
bGenes contain intragenic homopolymeric tracts indicating potential phase variable expression (Parkhill et al. 2000).
Figure 2 Cluster analysis performed using GeneSpring 3.2.12
software showing the relationship of all 11 Campylobacter jejuni
strains studied to each other based on their genomic composition
compared to the sequenced strain NCTC 11168.
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Table 3. Divergence in the 42.6 kb NCTC 11168 Capsule Biosynthetic Locus in the Campylobacter jejuni Strains Studied
Gene
name Functiona
Clone content
(%)
Phase
variableb 81116 81-176 X G1 P1 P2 P3 P4
PHLS
01
PHLS
02
PHLS
03
Cj1413 kpsS Cj1413 (67) + + + + + + + + + + +
Cj1414 kpsC Cj1413 (16) + + + + + + + + + + +
Cj1414 (50)
Cj1415 cysC Cj1414 (20) (+) + + + + + + + + + +
Cj1415 (100)
Cj1416 (17)
Cj1416 sugar Cj1416 (82) + + + + + + + + + + +
nucleotidyltransferase
Cj1417 GMP synthetase Cj1416 (22) + + + + + + + + + + +
Cj1417 (98)
Cj1418 phosphoenolpyruvate Cj1418 (39) + + + + + + + + + + +
synthase
Cj1419 methyltransferase Cj1418 (9) + + + + + + + + + + +
Cj1419 (77)
Cj1420 unknown Cj1420 (73)  + + + + + + + (+) + + +
Cj1421 sugar transferase Cj1421 (33)  (+) + + + + + + (+) + + +
Cj1422 sugar transferase Cj1422 (89)   +  + + + (+)  + + +
Cj1423 sugar-phosphate Cj1423 (100)  (+) (+) + + + (+) (+) + (+) +
nucleotidyltransferase Cj1424 (100)
Cj1425 (3)
Cj1424 gmhA2 Cj1423 (22) + + + + + + + + + + +
Cj1424 (100)
Cj1425 (4)
Cj1425 galactose kinase Cj1424 (22)  + (+)   + + + + + +
Cj1425 (100)
Cj1426 (20)
Cj1426 unknown Cj1425 (2)   +    +  (+) + + +
Cj1426 (100)
Cj1427 (46)
Cj1427 sugar-nucleotide Cj1427 (75)  +  + + + (+) + + + +
epimerase/dehydratase
Cj1428 fucose synthetase Cj1427 (28)  (+)  +  +   + + +
Cj1428 (100)
Cj1429 (6)
Cj1429 unknown Cj1428 (14)   +  +  +   + + +
Cj1429 (100)
Cj1430 (42)
Cj1430 nucleotide-sugar Cj1429 (29) + + + + + + + + + + +
epimerase/dehydratase Cj1430 (100)
Cj1431 (7)
Cj1431 glycosyltransferase Cj1431 (43)     + +   + + +
Cj1432 glycosyltransferase Cj1432 (45)      +   + + +
Cj1433 unknown Cj1432 (2)     + + +   + + +
Cj1433 (71)
Cj1434 galactosyltransferase Cj1434 (55)  +  + + + (+)  + + +
Cj1435 phosphoserine Cj1435 (100) (+) + + + + + (+) + + + +
phosphatase Cj1436 (4)
Cj1436 aminotransferase Cj1436 (89)  +  + + + (+) (+) + + +
Cj1437 aminotransferase Cj1437 (84)  (+)  +  +   + + +
Cj1438 (2)
Cj1438 galactosyltransferase Cj1438 (42)  (+)  + + + +  + + +
Cj1439 UDP-galactopyranose Cj1439 (75)    +  +   + + +
mutase
Cj1440 galactosyltransferase Cj1440 (52)  (+)  + (+) +   + + +
Cj1441 (11)
Cj1441 kfiD Cj1440 (3)     + +   + + +
Cj1441 (73)
Cj1442 glycosyltransferase Cj1442 (47) + + +  + (+) + + (+) + +
Cj1443 kpsF Cj1443 (63) + + + + + + + + + + +
Cj1444 kpsD Cj1444 (74) + + + + + + + + + + +
Cj1445 kpsE Cj1445 (65) + + + + + + + + + + +
Cj1447 (38)
Cj1447 kpsT Cj1445 (25) + + + + + (+) + + (+) + +
Cj1447 (100)
Cj1448 (13)
Cj1448 kpsM Cj1447 (44) + + (+) (+) + + + + + + +
Cj1448 (100)
A + or  indicates that the red/green hypridization signal intensity ratio is >0.5 or <0.5, respectively.
(+) indicates the possibility that the gene may be absent or highly divergent even though the red/green hybridization signal intensity ratio is
>0.5 (see Methods).
aPutative gene function based on annotation (Parkhill et al. 2000).
bGenes contain intragenci homopolymeric tracts indicating potential phase variable expression (Parkhill et al. 2000).
NB: Cj1446 was originally designated a CDS, but was unannotated in the final genome annotation (Parkhill et al. 2000).
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sule region, which encode the general capsule transport
mechanism, were conserved in all the strains studied (Ta-
ble 3).
C. jejuni LOS consists of a relatively conserved inner core
with a terminal outer core region that often varies in structure
between strains and can mimic human gangliosides (Moran
and Penner 1999). C. jejuni NCTC 11168 genes involved in
inner core biosynthesis include waaC, waaV, waaF, rfaE, and
rfaD. A positive hybridizing signal was obtained with genomic
DNA from 10 of 11 C. jejuni strains for the elements present-
ing waaC, and for all strains for waaV, waaF, rfaE, and rfaD
(Table 4). However, genes involved in C. jejuni NCTC 11168
LOS outer-core biosynthesis are absent or highly divergent in
a number of strains. Examples include Cj1139 or wlaN, a
-1,3-galactosyltransferase responsible for the addition of the
terminal galactose residue of the NCTC 11168 ganglioside
GM1-like LOS (Linton et al. 2000a). This gene is absent in
strains 81116, 81-176, P3, and P4 (Table 4). Other putative
outer-core sugar transferases such as glycosyltransferases
(Cj1135 and Cj1136) and galactosyltransferase (Cj1138) are
lacking in strains 81116, 81-176, P3, and P4 (Table 4). Also of
note are the genes involved in the sialylation of LOS (neuA1,
Table 4. Divergence in the 20.4 kb NCTC 11168 Lipo-oligosaccharide Biosynthetic Locus in the Campylobacter jejuni Strains
Studied
Gene
name Functiona
Clone content
(%)
Phase
variableb 81116 81-176 X G1 P1 P2 P3 P4
PHLS
01
PHLS
02
PHLS
03
Cj1131 galE Cj1131 (73) + + + + + + + + + + +
Cj1132 unknown Cj1132 (80) + + + + + + + + + + +
Cj1133 (11)
Cj1133 waaC Cj1132 (20) (+) + (+) (+) + (+) + +  + +
Cj1133 (100)
Cj1134 (19)
Cj1134 htrB Cj1134 (67) + + + + + + + + + + +
Cj1135 (4)
Cj1135 glycosyltransferase Cj1135 (53)  + + + + +  + + + +
Cj1136 glycosyltransferase Cj1136 (89)  (+) + + + +   + + +
Cj1137 (3)
Cj1137 unknown Cj1136 (13)  (+) + +  (+) (+)  + (+) +
Cj1137 (100)
Cj1138 (18)
Cj1138 galactosyltransferase Cj1138 (67)   + + (+) + (+)  + + +
Cj1139 wlaNc Cj1138 (30)    + + + +   + + +
Cj1139 (96)
Cj1140 cst Cj1140 (93)   + + + + (+)  + + +
Cj1141 (47)
Cj1141 neuBld Cj1140 (26)  + + + (+) +   + + +
Cj1141 (100)
Cj1142 (6)
Cj1142 neuCld Cj1141 (29)  (+) + + + +   + + +
Cj1142 (98)
Cj1143 neuAld Cj1143 (42)   + + + +   + + +
Cj1144 unknown Cj1143 (15)    + + + +   + + +
Cj1144 (75)
Cj1145 unknown Cj1143 (3)  (+) + + + +    (+) + +
Cj1144 (100)
Cj1145 (100)
Cj1146 (76)
Cj1146 waaV Cj1146 (89) + + + + + + (+) (+) + (+) +
Cj1148 (9)
Cj1148 waaF Cj1148 (80) + + + + + + + + + + +
Cj1149 (2)
Cj1149 gmhA Cj1149 (92) + + + + + + + + + + +
Cj1150 (27)
Cj1150 rfaE Cj1149 (23) + + + + + + (+) (+) + + (+)
Cj1150 (94)
Cj1151 rfaD Cj1150 (35) + + + + + + + + + + +
Cj1151 (83)
Cj1152 phosphatase Cj1152 (76) + + + + + + + + + + +
Cj1153 (100)
A + or  indicates that the red/green hypridization signal intensity ratio is >0.5 or <0.5, respectively.
(+) indicates the possibility that the gene may be absent or highly divergent even though the red/green hybridization signal intensity ratio is
>0.5 (see Methods).
aPutative gene function based on annotation (Parkhill et al. 2000).
bGenes contain intragenic homopolymeric tracts indicating potential phase variable expression (Parkhill et al. 2000).
cLinton et al. 2000b.
dLinton et al. 2000a.
NB: Cj1447 was originally designated a CDS, but was unannotated in the final genome annotation (Parkhill et al. 2000).
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neuB1, and neuC1), which are absent in strains 81116, P3, and
P4 (Table 4; Linton et al. 2000b).
Validation of Microarray Data
To validate microarray data, PCR and sequence analysis of a
number of variable genes from the strains studied was per-
formed. A strategy was used to amplify PCR products across
putative deletions defined by the microarray data, then to
sequence these PCR products to define the precise location of
the deletion. Analysis of sequence data generated was per-
formed by BLAST search (Altschul et al. 1997). Two single
gene deletions (Cj0008 and Cj1585) and two small gene clus-
ters (Cj0055–Cj0058 and Cj0565–Cj0569) were selected in the
four strains 81116, 81-176, X, and G1. Cj0008 is a gene with
unknown function, but an ortholog of HP0938 in the H. pylori
26695 genome. Cj1585 is a probable oxidoreductase. The
cluster Cj0055–Cj0058 consists of two genes of unknown
function and two genes coding for possible periplasmic pro-
teins, all with no match in the H. pylori 26695 genome, and
the cluster Cj0565–Cj0569 contains genes with no known
function and no match with the H. pylori 26695 genome,
suggesting that these clusters may be specific to Campylobacter
species. These studies are summarized in Table 5 and clearly
validate the microarray hybridization results, which have
given consistently reproducible data. Additionally, the micro-
array data confirm reported data on the neuB genes involved
in sialylation in strains 81116, G1, P1, P2, and P3 (Linton et
al. 2000b), the wlaN gene involved in LOS biosynthesis, in
strains P1, P2, P3, and P4 (Linton et al. 2000a), and deletions
in both the flagellin modification locus and the capsule bio-
synthesis locus in strains 81116, 81-176, X, and G1 (A.V.
Karlyshev, unpubl.).
DISCUSSION
Using a single pair of vector primers, we have constructed a
low-cost whole genome C. jejuni NCTC 11168 DNA microar-
ray representing all 1654 annotated genes that were amplified
from the pUC18 clones sequenced as part of the genome
project (Parkhill et al. 2000). Eleven C. jejuni strains of diverse
origin were analyzed with respect to the genome content of
the sequenced strain, revealing extensive genetic diversity
within this species. One caveat with the data generated with
this microarray is that some genes may be scored as present,
when in fact they are absent or highly divergent. This is be-
cause of either adjacent gene sequences on some of the PCR
products on the microarray or cross-hybridization with an-
other part of the genome. If the gene represented by the PCR
product on the array is absent, but an adjacent gene is present,
this will potentially increase the red/green hybridization sig-
nal intensity ratio. If this ratio is increased above 0.5, using
our data analysis filtering method, the gene will be scored as
present. Conversely, any gene scored as absent should be ac-
curate within the limits of array hybridization specificity and
sensitivity. Therefore, although the microarray has limita-
tions, it is suitable for genomic comparisons where data gen-
erated is qualitative. The major advantage of using clones di-
rectly from genome projects is an inexpensive and efficient
alternative for the construction of DNA microarrays, and this
principle could be applied widely where random shot-gun
libraries are used for sequencing.
Of the 1654 annotated genes analyzed, 1300 (78.6%) ap-
peared to be common to all strains and can be defined as C.
jejuni core genes. As expected, these genes mainly encoded
housekeeping functions such as metabolic, biosynthetic, cel-
lular, and regulatory processes, as in the case of the closely
related pathogen H. pylori (Salama et al. 2000). By contrast,
determinants encoding surface-located structures such as the
flagellin synthesis and modification system, LOS, and capsule
were absent or highly divergent in one or more strains stud-
ied. These determinants probably relate to functions impor-
tant in survival, transmission, and pathogenesis, indicating
that selective pressures have driven profound evolutionary
changes to create a diverse Campylobacter species. However,
not all putative virulence determinants, including several sur-
face proteins, showed variability. Genes encoding cytolethal
distending toxin (Pickett et al. 1996), flagellar structural pro-
teins (Wassenaar et al. 1991), phospholipase A (Grant et al.
1997), the PEB antigenic surface proteins (Pei et al. 1991), and
proteins potentially involved in host pathogen interactions
such as CiaB (Konkel et al. 1999), CadF (Konkel et al. 1997),
and CheY (Yao et al. 1997) were present in all strains, indi-
cating that these proteins are indispensable for C. jejuni to
cause disease in humans.
Whole genome analysis shows extensive genome diver-
sity among the 12 C. jejuni strains studied, with at least 354
genes (21.4%) missing from at least one strain. This is likely to
be an underestimate of the number of variable genes in C.
jejuni, owing to the relatively small number of strains ana-
lyzed and the nature of the microarray, which sometimes con-
tained DNA adjacent to the target gene. The percentage of
variable genes is remarkably similar to that observed for the
closely related gastric pathogen H. pylori, in which 22% of
genes were variable in the 15 strains studied (Salama et al.
2000). The hybridization conditions and criteria for designat-
ing nonhybridizing genes were, as far as is possible to deter-
Table 5. Validation of Microarray Data by PCR and Sequence Analysis
Strain
Cj0008 Cj1585 Cj0055–Cj0058 Cj0565–Cj0569
array PCR Sequencing Array PCR Sequencing Array PCR Sequencing Array PCR Sequencing
81116     a b     a c
81-176 + + +  a b + + +  a c
X    + + + + + + + + +
G1    + + + + + + + + +
A + or  indicates the presence or absence, respectively, or a gene indicated by microarray data, alongside the subsequent analysis data.
aPutative insertion identified by PCR, rather than a deletion.
bSequence analysis suggests the presence of an anaerobic dimethyl sulphoxide reductase ortholog adjacent to Cj1584.
cAnalysis of sequence data adjacent to Cj0564 shows no matches with any database entry.
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mine, the same in both studies. Curiously, in contrast to H.
pylori, the genome sequence of C. jejuni NCTC 11168 revealed
no transposons, phage remnants, or insertion sequence ele-
ments and very few repeat sequences (Parkhill et al. 2000).
The mechanisms to generate genetic diversity in C. jejuni
therefore remain unclear. However, C. jejuni is naturally com-
petent, and this linked to a high recombination rate may
contribute to genetic diversity. Recent multilocus sequence
typing for C. jejuni has indicated that intraspecies and inter-
species horizontal genetic exchange for this species are com-
mon (Dingle et al. 2001). The restriction/modification sys-
tems in C. jejuni appear divergent, with only G1, PHLS01,
PHLS02, and PHLS03 of the 11 strains being similar to NCTC
11168. In H. pylori, numerous strain-specific restriction/
modification systems have been found, and DNA methyl-
ation patterns have been shown to vary substantially among
strains (Ando et al. 2000; Xu et al. 2000). Recently, the se-
quencing of a second E. coli strain has also shown restriction/
modification systems to be variable (Perna et al. 2001). El-
evated divergence of these systems may be associated with the
positive selection of subpopulations that contribute to ge-
netic diversity.
Compared to most genomes from enteric bacteria, the
NCTC 11168 DNA sequence has a characteristically constant
30.6% G + C content over the genome. However, it is notice-
able that where there are differences, these occur in loci that
appear to vary between strains. For example, the NCTC 11168
G + C content in the capsule biosynthesis region is 27.6%
over 42.6 kb, in the LOS biosynthesis region it is 27.8% over
20.4 kb, and the restriction modification genes Cj1549 and
Cj1553 have a G + C content of 34.3% and 37.8%, respec-
tively. The significantly variable G + C content of these re-
gions indicates that they may have been acquired by horizon-
tal genetic exchange and introduced relatively recently dur-
ing the evolution of the C. jejuni genome. Additionally, phase-
variable, or contingency genes, that were originally identified
directly from sequencing the random shotgun library of
NCTC 11168 (Parkhill et al. 2000), appear to be absent in
several strains (Tables 2–4). These include four of six such
genes from the capsule locus, both phase-variable genes in the
LOS locus, and a phase-variable restriction/modification sys-
tem, indicating that these genes are dispensable but are prob-
ably required to generate diversity on the C. jejuni cell surface.
Analysis of the flagellin modification locus shows similar
hybridization efficiencies among all strains except for the
laboratory passaged strains 81116 and 81-176 (Fig. 1). The loss
of this region, which has been confirmed for 81116 using PCR
analysis (A.V. Karlyshev, unpubl.), may be caused by homolo-
gous recombination through the near identical genes Cj1318
and Cj1336 that flank the deletion in NCTC 11168 (Parkhill
et al. 2000). Such a recombinant event leading to this deletion
may be expected in strains that have been extensively pas-
saged in the laboratory over a 20-year period.
The Penner serotyping system has been used for differ-
entiating C. jejuni strains for more than 20 years (Penner and
Hennessy 1980). It was presumed that the Penner serotyping
antigen arose from the C. jejuni surface-encoded O antigen.
Recently, we demonstrated that the capsule was responsible
for the Penner serotyping antigen (Karlyshev et al. 2000a).
The DNAmicroarray data presented here provides further evi-
dence that the capsule accounts for Penner serospecificity in
that all four strains of O:2 serotype showed complete conser-
vation of the capsule biosynthesis locus compared to the se-
quenced strain NCTC 11168 (also serotype O:2; Table 3). The
seven non-O:2 serotype strains lacked between 5 and 17 genes
located in the putative capsule biosynthetic locus of NCTC
11168. By contrast, scrutiny of the LOS biosynthesis region
showed that two non-O:2 serotypes (strains X and G1) had
complete conservation of the LOS biosynthesis locus com-
pared to the sequenced strain and that the O:2 serotype
strains P2 and PHLS01 lack a single gene compared to NCTC
11168 (Table 4). Ten percent of C. jejuni strains are untypable
using the Penner serotyping method (e.g., strain X in this
study). Further genetic analysis of the capsule region among
many more C. jejuni serotypes should enable the genetic basis
of Penner serospecificity to be determined, allowing the de-
velopment of improved genotyping methods to distinguish
between C. jejuni strains. The microarray data support the
hypothesis that the region flanked by the kps genes (see Table
3) is the capsule biosynthetic region, having a similar overall
arrangement to group II/III capsules in E. coli (Roberts 1996).
C. jejuni strain diversity combined with variable host re-
sponses results in a complex spectrum of disease outcomes,
ranging from asymptomatic colonization to severe inflamma-
tory diarrhoea. In addition, chronic sequelae are also associ-
ated with C. jejuni infection, including irritable bowel syn-
drome and neuropathological complications such as Guillain-
Barré and Miller Fisher syndromes. Variable genes identified
through whole genome analysis may encode factors contrib-
uting to different disease outcomes and to the survival of the
organism in different ecological niches. Comparison of a
larger collection of strains with known clinical histories
should allow associative traits to be determined for subpopu-
lations of strains that are important in specific disease out-
comes. A precise understanding of genetic differences be-
tween C. jejuni strains should also allow the identification of
improved epidemiological markers and the development of
rational approaches to reduce this problematic pathogen
from the food chain.
METHODS
Bacterial Strains and Growth Conditions
The C. jejuni strains used in this study and relevant back-
ground information are shown in Table 1. Strains 81116 and
81-176 are laboratory strains that have been extensively stud-
ied. Strain X was isolated from a patient with noncomplicat-
ing gastroenteritis, whereas strain G1 was isolated from a pa-
tient with gastroenteritis who later developed GBS. Strains P1,
P2, P3, and P4 are the first four Penner serotype reference
strains, and the PHLS strains were selected as recent clinical
isolates, all with serotype O:2. Bacteria were grown on blood
agar plates, consisting of Columbia Agar Base (Oxoid) supple-
mented with 7% (v/v) defibrinated horse blood (TCS Micro-
biology), in a microaerobic atmosphere at 37°C.
Construction of a C. jejuni NCTC 11168
DNA Microarray
A tiling program was designed to select a minimum set of
clones representing all 1731 initially identified CDSs from the
8–10-fold redundant pUC18 library from the C. jejuni NCTC
11168 genome project (Parkhill et al. 2000). Plasmid DNA
from each of the selected clones was transferred to 19 96-well
plates. PCR amplicons were prepared in 100-µL reactions in
96-well plates using standard vector primers (M13 forward
and M13 reverse). All PCR amplifications and liquid handling
were performed using a RoboAmp 4200 (MWG-Biotech). The
amplicons were evaluated on agarose gels to ensure they were
of the expected size and concentration. A small sample of PCR
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products was sequenced to confirm that the expected gene
had been amplified. Then 50 µL of each successful PCR reac-
tion was ethanol-precipitated and resuspended in 10 µL of
50% (v/v) DMSO in H2O. The microarray was prepared by the
robotic printing of these vector primer-generated PCR prod-
ucts representing each gene in the C. jejuni NCTC 11168 ge-
nome onto CMT-GAPS-coated glass slides (Corning), using a
Microgrid I microgridding robot (Bio Robotics). We used a
4 4 split pin configuration with a center-to-center spot
spacing of 400 µm, producing spots with a diameter of ∼150
µm. After printing, free amino groups on the coated glass
slides were acetylated with 5.5 g of succinic anhydride in 350
mL of borate-buffered 1-methyl-2-pyrrolidinone at pH 8.
Slides were stored in microscope slide boxes in a cool, dry
environment and used within 1 mo.
Labeling of Genomic DNA
Genomic DNA was isolated from 48-h plate-grown C. jejuni
strains using the Wizard Genomic DNA Purification Kit (Pro-
mega). Whole genomic DNA was used as a template for direct
incorporation of fluorescent analogs (Cy3 and Cy5 dCTP) by
a randomly primed polymerization reaction. Briefly, 3 µg of
template DNA and 9 µg of random hexamers (GIBCO BRL) in
a reaction volume of 41.5 µL were denatured at 95°C for 5 min
and snap cooled on ice. Then 5 µL of 10 Klenow buffer (USB
Corporation), 1.5 µL of Cy-dye-labeled dCTP (Amersham
Pharmacia Biotech), 1 µL of dNTP solution (5 mM each dATP,
dGTP, and dTTP, plus 2 mM dCTP), and 10 U of Klenow (the
large fragment of DNA polymerase I, exonuclease-free; USB
Corporation) were added. Test strain DNA was labeled with
Cy5-dCTP and the control NCTC 11168 strain DNA with Cy3-
dCTP. The labeling reactions were incubated at 37°C for 90
min.
DNA Microarray Hybridizations
Whole genome DNA comparisons were performed, compar-
ing both laboratory strains and clinical isolates listed in Table
1 against the sequenced strain NCTC 11168. Microarray slides
were incubated in a prehybridization buffer (3.5 SSC buffer,
0.1% SDS, 10 mg/mL BSA) at 60°C for 20 min. After prehy-
bridisation, slides were washed in distilled water for 1 min,
followed by a 1-min wash in isopropanol. Labeled DNA from
the test and control strains were coprecipitated in the pres-
ence of 10 µg of tRNA and resuspended in a total volume of 16
µL with final concentration of 4 SSC buffer and 0.3% SDS.
The hybridization mixture was denatured at 95°C for 2 min,
cooled slowly to room temperature, applied to the microar-
ray, and covered with a 22-mm2 coverslip. The slide was
placed in a waterproof hybridization chamber (CMT Hybrid-
ization Chambers, Corning) for hybridization in a 60°C wa-
terbath overnight. After hybridization, slides were washed in
1 SSC buffer with 0.06% SDS for 2 min, followed by two
washes in 0.06 SSC buffer, each for 2 min.
Data Acquisition and Analysis
Slides were scanned with a ScanArray 3000 (GSI Lumonics)
following the manufacturer’s guidelines. Fluorescent spot in-
tensities were quantified using ImaGene 3.0 (BioDiscovery
Inc.) software. For each spot, background fluorescence was
subtracted from the average spot fluorescence to produce a
channel-specific value. The data were further analyzed using
GeneSpring 3.2.12 (Silicon Genetics) software. The geomet-
ric mean of the normalized red/green ratio was calculated for
each test strain using data from three array experiments. Spots
were excluded for low signal (<100 units in the Cy3 channel),
and a cutoff for the normalized red/green ratio of <0.5 was
used to create gene deletion lists using the GeneSpring
3.2.12 software.
If a gene was absent, but was represented by a clone
containing adjacent genes that were present, then the red/
green hybridisation signal intensity ratio could be raised
above 0.5 and the gene subsequently scored as present. If a
gene shared enough homology with other genes in the ge-
nome to allow cross-hybridization events, the same situation
could occur. It was important therefore to consider both (a)
the composition of each clone representing each gene on the
array, and (b) the possibility of cross-hybridization of each
clone with the rest of the genome. The possibility of cross-
hybridization was analyzed by BLASTN analysis of the se-
quence of each clone used on the array against the whole
genome sequence. This showed that there is very little signifi-
cant cross-hybridization between C. jejuniNCTC 11168 genes.
These data are available on-line at http://www.sghms.ac.uk/
depts/medmicro/bugs/GR-1858. A file showing the composi-
tion of each clone used to represent each gene on the array is
also available on-line. To highlight these considerations in
the results presented in Tables 2, 3, and 4, an arbitrary scoring
system was used to highlight genes scored as present that may
in fact be absent. A gene scored as present was marked (+)
rather than + if that gene was represented on the microarray
by (a) an adjacent gene clone or multiple gene clone with a
red/green ratio between 0.5 and 0.6; (b) a single gene clone or
an adjacent gene clone with significant predicted cross-
hybridization with a red/green ratio between 0.5 and 0.75; or
(c) a multiple gene clone with significant predicted cross-
hybridization with a red/green ratio between 0.5 and 0.9.
Validation of Microarray Data by PCR
and Sequencing
PCR primers were designed to approach both the 5 and 3
edges of predicted deletions so that the amplified region
would span the missing locus for those strains in which it is
deleted. Primer design was aided by the use of Artemis 3.0
software (Rutherford et al. 2000) to visualize the edges of the
predicted deletions. Both standard PCR using primer pairs
and PCR using a single primer (Karlyshev et al. 2000b) were
performed. The resulting amplicons were sequenced using the
dideoxynucleotide chain termination method with a PRISM
BigDye sequencing kit (PE Applied BioSystems) with primers
designed to be internal to the original PCR primer(s).
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